Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 163-170

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Purine Nucleoside Analogues for Hematological Malignancies

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 123-136

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed

By Tracy Swainston Harrison   Lesley J. Scott  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 359-370

Adis International

Access to resources Recommend Favorite

Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines

By Kitazono-Saitoh Miyako   Takiguchi Yuichi   Kitazono Satoru   Ashinuma Hironori   Kitamura Atsushi   Tada Yuji   Kurosu Katsushi   Sakaida Emiko   Sekine Ikuo   Tanabe Nobuhiro   Tagawa Masatoshi   Tatsumi Koichiro  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 33-40

Spandidos Publications

Access to resources Recommend Favorite

Revisions of General Guidelines for the Preclinical Toxicology of New Cytotoxic Anticancer Agents in Europe

By Cancer Research Campaign CRC Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer EORTC New Drug Development Office   Burtles S.S.   Newell D.R.   Henrar R.E.C.   Connors T.A.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 408-410

Elsevier

Access to resources Recommend Favorite